Cargando…
Interstitial pneumonia with autoimmune features: challenges and controversies
The presence of clinical, serological and/or radiological features suggestive, but not confirmatory, of a defined connective tissue disease in patients with interstitial lung disease is a relatively frequent occurrence. In 2015, the European Respiratory Society and the American Thoracic Society prop...
Autores principales: | , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
European Respiratory Society
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9488577/ https://www.ncbi.nlm.nih.gov/pubmed/34937706 http://dx.doi.org/10.1183/16000617.0177-2021 |
_version_ | 1784792689228644352 |
---|---|
author | Mackintosh, John A. Wells, Athol U. Cottin, Vincent Nicholson, Andrew G. Renzoni, Elisabetta A. |
author_facet | Mackintosh, John A. Wells, Athol U. Cottin, Vincent Nicholson, Andrew G. Renzoni, Elisabetta A. |
author_sort | Mackintosh, John A. |
collection | PubMed |
description | The presence of clinical, serological and/or radiological features suggestive, but not confirmatory, of a defined connective tissue disease in patients with interstitial lung disease is a relatively frequent occurrence. In 2015, the European Respiratory Society and the American Thoracic Society proposed classification criteria for the interstitial pneumonia with autoimmune features (IPAF) research entity to capture such patients in a standardised manner, with the intention of nurturing clinical research. This initiative resulted in the publication of several series of IPAF patients, with significant variation between cohorts in clinical characteristics, outcome and the application of IPAF criteria in patient selection. From this increasing body of published work, it has become apparent that revision of IPAF criteria is now required in order to justify the eventual designation of IPAF as a standalone diagnostic term, as opposed to a provisional entity put forward as a basis for clinical research. This review covers the current state of IPAF, conclusions that can and cannot be drawn from the IPAF evidence base, and ongoing uncertainties that require further expert group consideration. |
format | Online Article Text |
id | pubmed-9488577 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | European Respiratory Society |
record_format | MEDLINE/PubMed |
spelling | pubmed-94885772022-11-14 Interstitial pneumonia with autoimmune features: challenges and controversies Mackintosh, John A. Wells, Athol U. Cottin, Vincent Nicholson, Andrew G. Renzoni, Elisabetta A. Eur Respir Rev Reviews The presence of clinical, serological and/or radiological features suggestive, but not confirmatory, of a defined connective tissue disease in patients with interstitial lung disease is a relatively frequent occurrence. In 2015, the European Respiratory Society and the American Thoracic Society proposed classification criteria for the interstitial pneumonia with autoimmune features (IPAF) research entity to capture such patients in a standardised manner, with the intention of nurturing clinical research. This initiative resulted in the publication of several series of IPAF patients, with significant variation between cohorts in clinical characteristics, outcome and the application of IPAF criteria in patient selection. From this increasing body of published work, it has become apparent that revision of IPAF criteria is now required in order to justify the eventual designation of IPAF as a standalone diagnostic term, as opposed to a provisional entity put forward as a basis for clinical research. This review covers the current state of IPAF, conclusions that can and cannot be drawn from the IPAF evidence base, and ongoing uncertainties that require further expert group consideration. European Respiratory Society 2021-12-22 /pmc/articles/PMC9488577/ /pubmed/34937706 http://dx.doi.org/10.1183/16000617.0177-2021 Text en Copyright ©The authors 2021 https://creativecommons.org/licenses/by-nc/4.0/This version is distributed under the terms of the Creative Commons Attribution Non-Commercial Licence 4.0. For commercial reproduction rights and permissions contact permissions@ersnet.org (mailto:permissions@ersnet.org) |
spellingShingle | Reviews Mackintosh, John A. Wells, Athol U. Cottin, Vincent Nicholson, Andrew G. Renzoni, Elisabetta A. Interstitial pneumonia with autoimmune features: challenges and controversies |
title | Interstitial pneumonia with autoimmune features: challenges and controversies |
title_full | Interstitial pneumonia with autoimmune features: challenges and controversies |
title_fullStr | Interstitial pneumonia with autoimmune features: challenges and controversies |
title_full_unstemmed | Interstitial pneumonia with autoimmune features: challenges and controversies |
title_short | Interstitial pneumonia with autoimmune features: challenges and controversies |
title_sort | interstitial pneumonia with autoimmune features: challenges and controversies |
topic | Reviews |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9488577/ https://www.ncbi.nlm.nih.gov/pubmed/34937706 http://dx.doi.org/10.1183/16000617.0177-2021 |
work_keys_str_mv | AT mackintoshjohna interstitialpneumoniawithautoimmunefeatureschallengesandcontroversies AT wellsatholu interstitialpneumoniawithautoimmunefeatureschallengesandcontroversies AT cottinvincent interstitialpneumoniawithautoimmunefeatureschallengesandcontroversies AT nicholsonandrewg interstitialpneumoniawithautoimmunefeatureschallengesandcontroversies AT renzonielisabettaa interstitialpneumoniawithautoimmunefeatureschallengesandcontroversies |